XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
GOODWILL AND INTANGIBLE ASSETS (Tables)
9 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill

A reconciliation of changes in the Company’s goodwill by reportable segment were as follows:
(in millions) Technologies & Equipment Consumables Total
Balance at December 31, 2020
Goodwill $ 5,985  $ 894  $ 6,879 
Accumulated impairment losses (2,893) —  (2,893)
Goodwill, net $ 3,092  $ 894  $ 3,986 
Acquisition related additions (a) 107  —  107 
Translation and other (140) 47  (93)
Balance at September 30, 2021
Goodwill $ 5,952  $ 941  $ 6,893 
Accumulated impairment losses (2,893) —  (2,893)
Goodwill, net $ 3,059  $ 941  $ 4,000 
(a) Refer to Note 5, “Business Combinations” for more information regarding recent acquisitions.
Schedule of Definite-lived and Indefinite-lived Intangible Assets

Identifiable definite-lived and indefinite-lived intangible assets were as follows:
September 30, 2021 December 31, 2020
(in millions) Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Developed technology and patents $ 1,752  $ (743) $ 1,009  $ 1,681  $ (677) $ 1,004 
Tradenames and trademarks 269  (76) 193  273  (70) 203 
Licensing agreements 36  (31) 37  (30)
Customer relationships 1,105  (533) 572  1,142  (494) 648 
Total definite-lived $ 3,162  $ (1,383) $ 1,779  $ 3,133  $ (1,271) $ 1,862 
Indefinite-lived tradenames and trademarks $ 610  $ —  $ 610  $ 642  $ —  $ 642 
In-process R&D (a)
13  —  13  —  —  — 
Total indefinite-lived $ 623  $ —  $ 623  $ 642  $ —  $ 642 
Total identifiable intangible assets $ 3,785  $ (1,383) $ 2,402  $ 3,775  $ (1,271) $ 2,504 
(a) Intangible assets acquired in a business combination that are in-process and used in research and development (“R&D”) activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed.